Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check6 days agoChange DetectedA site-wide NIH banner announces a terminology transition and links to updates and FAQs. The footer revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the study page still displays a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with a minimal header and a Home link. This indicates access to the study record is blocked rather than updated with new study information.SummaryDifference20%

- Check41 days agoChange DetectedRevision metadata on the study page was updated from v3.6.6 to v3.7.0. This indicates a software update to the page rendering or underlying platform rather than changes to the study content.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a minor update to the page version.SummaryDifference0.1%

- Check76 days agoChange DetectedThe site’s revision tag changed from v3.6.4 to v3.6.5, reflecting a minor system update with no impact to the study content or user-facing information.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.